Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

Abstract Background To investigate the ameliorating effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood glucose control in patients with type 2 diabetes mellitus who were previously untreated with or who have a poor responsive to existing antidiabetic drugs. Methods Sitagliptin (50 m...

Full description

Bibliographic Details
Main Authors: Hiroshi Sakura, Naotake Hashimoto, Kazuo Sasamoto, Hiroshi Ohashi, Sumiko Hasumi, Noriko Ujihara, Tadasu Kasahara, Osamu Tomonaga, Hideo Nunome, Masashi Honda, Yasuhiko Iwamoto, for the JAMP Study Investigators
Format: Article
Language:English
Published: BMC 2016-12-01
Series:BMC Endocrine Disorders
Subjects:
Sitagliptin
Diabetes mellitus
DPP-4 inhibitor
HbA1c
Glimepiride
Online Access:http://link.springer.com/article/10.1186/s12902-016-0149-z

Internet

http://link.springer.com/article/10.1186/s12902-016-0149-z

Similar Items